October 2, 2019 — On October 2, 2019, the FDA said it found “unacceptable levels” of NDMA in samples of ranitidine in its testing.
Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.